1st Quarter - Report

ALERE INC. for ALERE INC.

Period 1st Quarter 2017 Filed Apr 19, 2017 Signed by Seth Radus, VP, Government Affairs

Official filing
Firm
ALERE INC.
Client
ALERE INC.
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA regulation of In Vitro diagnostic laboratory testing World Health Organization influenza preparedness program financing

LobbyistCovered position, as disclosed
SETH M RADUS —

Contacted: SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Protecting Access to Medicare Act of 2014, Sec. 216 regarding implementation of new Medicare reimbursement system for laboratory tests Medicare reimbursement for point-of-care testing Medicare competitive bidding program for diabetic supplies

LobbyistCovered position, as disclosed
SETH M RADUS —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.